Back to Search Start Over

Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children.

Authors :
Horellou P
de Chalus A
Giorgi L
Leroy C
Chrétien P
Hacein-Bey-Abina S
Bourgeois C
Mariette X
Serguera C
Le Grand R
Deiva K
Source :
Frontiers in immunology [Front Immunol] 2021 Jun 16; Vol. 12, pp. 679770. Date of Electronic Publication: 2021 Jun 16 (Print Publication: 2021).
Publication Year :
2021

Abstract

Background: Myelin oligodendrocytes glycoprotein (MOG) antibody-associated disease (MOGAD) represent 25% of pediatric acquired demyelinating syndrome (ADS); 40% of them may relapse, mimicking multiple sclerosis (MS), a recurrent and neurodegenerative ADS, which is MOG-Abs negative.<br />Aims: To identify MOG antigenic immunological response differences between MOGAD, MS and control patients, and between relapsing versus non-relapsing subgroups of MOGAD.<br />Methods: Three groups of patients were selected: MOGAD (n=12 among which 5 relapsing (MOGR) and 7 non-relapsing (MOGNR)), MS (n=10) and control patients (n=7). Peripheral blood mononuclear cells (PBMC) collected at the time of the first demyelinating event were cultured for 48 h with recombinant human (rh)-MOG protein (10 μg/ml) for a specific stimulation or without stimulation as a negative control. The T cells immunophenotypes were analyzed by flow cytometry. CD4 <superscript>+</superscript> T cells, T helper (Th) cells including Th1, Th2, and Th17 were analyzed by intracellular staining of cytokines. Regulatory T cells (T <subscript>regs</subscript> , Foxp3 <superscript>+</superscript> ), CD45RA <superscript>-</superscript> Foxp3 <superscript>+</superscript> T <subscript>regs</subscript> and subpopulation naive T <subscript>regs</subscript> (CD45RA <superscript>+</superscript> Foxp3 <superscript>int</superscript> ), effector T <subscript>regs</subscript> (CD45RA <superscript>-</superscript> Foxp3 <superscript>high</superscript> ) and non-suppressive T <subscript>regs</subscript> (CD45RA <superscript>-</superscript> Foxp3 <superscript>int</superscript> ) proportions were determined.<br />Results: The mean onset age of each group, ranging from 9.9 to 13.8, and sex ratio, were similar between MOGR, MOGNR, MS and control patients as analyzed by one-way ANOVA and Chi-square test. When comparing unstimulated to rh-MOG stimulated T cells, a significant increase in the proportion of Th2 and Th17 cells was observed in MOGAD. Increase of Th17 cells was significant in MOGNR (means: 0.63 ± 0.15 vs. 1.36 ± 0.43; Wilcoxon-test p = 0.03) but not in MOGR. CD4 <superscript>+</superscript> T <subscript>regs</subscript> were significantly increased in MOGNR (means: 3.51 ± 0.7 vs. 4.59 ± 1.33; Wilcoxon-test p = 0.046) while they decreased in MOGR. CD45RA <superscript>-</superscript> Foxp3 <superscript>+</superscript> T <subscript>regs</subscript> were significantly decreased in MOGR (means: 2.37 ± 0.23 vs. 1.99 ± 0.17; paired t-test p = 0.021), but not in MOGNR. MOGR showed the highest ratio of effector T <subscript>regs</subscript> /non suppressive-T <subscript>regs,</subscript> which was significantly higher than in MOGNR.<br />Conclusions: Our findings suggest that CD4 <superscript>+</superscript> Th2 and Th17 cells are involved in the pathophysiology of MOGAD in children. The opposite response of T <subscript>regs</subscript> to rh-MOG in MOGNR, where CD4 <superscript>+</superscript> T <subscript>regs</subscript> increased, and in MOGR, where CD45RA <superscript>-</superscript> Foxp3 <superscript>+</superscript> T <subscript>regs</subscript> decreased, suggests a probable loss of tolerance toward MOG autoantigen in MOGR which may explain relapses in this recurrent pediatric autoimmune disease.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Horellou, de Chalus, Giorgi, Leroy, Chrétien, Hacein-Bey-Abina, Bourgeois, Mariette, Serguera, Le Grand and Deiva.)

Details

Language :
English
ISSN :
1664-3224
Volume :
12
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
34220827
Full Text :
https://doi.org/10.3389/fimmu.2021.679770